Note to Authors

Please note that new standards for page and color publication fees are in effect starting with Volume 2, Issue 2 of mAbs. For additional information and a guide to estimate charges please click here.

In this issue

mAbs
Volume 2, Issue 1
January/February 2010
View current issue
About the cover
The cover illustration shows a sketch of possible arrangements of oligomeric forms of single chain  IgG. Higher molecular forms are found in size exclusion...
Continue reading


About the Journal

mAbs accepted for inclusion for Medline  11.6.09

In January of 2009 mAbs, the first international peer-reviewed journal of its kind to focus exclusively on monoclonal antibodies, was launched. We believe that this is an excellent time to start the journal because of the increasing focus on mAbs as therapeutics. There has been a rapid increase in mAb R&D by academia, government and industry located world wide. Novel mAb therapeutics are entering clinical study by commercial sponsors at a record pace (Figure 1) that is predicted to continue well into the future. MAbs have proven successful in the clinic (Table 1). In addition, a global market has emerged for the products - several novel mAbs not yet available in the US or EU are now approved in China.


HINARI

Landes Bioscience gladly participates in the World Health Organizations' Access to Research Initiative (HINARI) to provide free online access to all papers published in mAbs to scientists in developing countries worldwide.

Read more about the HINARI initiative.

Editor-in-Chief

Janice M. Reichert, Ph.D.

Email the Managing Editor.

Print ISSN: 1942-0862
Online ISSN: 1942-0870 DOI: 10.4161/mabs

Most Popular Downloads

01 Jan 10
Antibodies to watch in 2010
Janice M. Reichert
01 Mar 09
High level expression of functional human IgMs in human PER.C6® cells
Anna Tchoudakova, Frank Hensel, Alec Murillo, et al.
01 Nov 09
01 Sep 09
Golimumab
Sohini Mazumdar and David Greenwald
01 Mar 09

Meetings of interest

Antibody Engineering and Design
February 23, 2010, Frankfurt, Germany

Cell Line Development and Engineering
February 24–25, 2010, San Francisco, CA USA

Antibody Biology and Engineering

March 7–12, 2010, Ventura, CA USA

Bio-Europe Spring 2010
March 8–10, 2010, Barcelona, Spain

Keystone Symposia: New Paradigms in Cancer Therapeutics
March 23–28, 2010, Victoria, British Columbia, Canada

Links of Interest







Advertisements